| Completed | CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib Metastatic Castration-Resistant Prostate Cancer, Ovarian Cancer, Epithelial Ovarian Cancer | Phase 3 | 2021-03-22 |
| Terminated | A Study to Evaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR Genes Solid Tumor | Phase 2 | 2020-01-16 |
| Completed | Study of Oral Rucaparib With Other Anticancer Agents in Metastatic Castration Resistant Prostate Cancer Patien Metastatic Castration Resistant Prostate Cancer | Phase 1 | 2019-12-05 |
| Completed | A Disease Registry Encompassing the Care Of Patients With Multiple Myeloma on Panobinostat Multiple Myeloma | — | 2019-11-04 |
| Terminated | A Study to Evaluate Rucaparib in Combination With Nivolumab in Patients With Selected Solid Tumors (ARIES) Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma | Phase 2 | 2019-08-23 |
| Terminated | A Study to Evaluate Rucaparib in Combination With Other Anticancer Agents in Participants With a Solid Tumor ( Ovarian Cancer, Triple-negative Breast Cancer, Urothelial Carcinoma | Phase 1 / Phase 2 | 2019-06-28 |
| Completed | Drug-Drug Interaction Study of Rucaparib, Rosuvastatin and Oral Contraceptives Neoplasms | Phase 1 | 2019-04-25 |
| Terminated | Rucaparib in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Bladder Cancer, Urothelial Carcinoma, Metastatic Urothelial Carcinoma | Phase 2 | 2018-06-01 |
| Active Not Recruiting | A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Respo Epithelial Ovarian Cancer, Primary Peritoneal, Fallopian Tube Cancer | Phase 3 | 2018-05-14 |
| Completed | Rucaparib Hepatic Impairment Study in Patients With a Solid Tumor Neoplasms | Phase 1 | 2018-02-27 |
| Completed | A Study of Rucaparib in Japanese Patients With a Previously-treated Solid Tumor Advanced Solid Tumor | Phase 1 | 2018-02-06 |
| Completed | A Study of Rucaparib Versus Physician's Choice of Therapy in Participants With Metastatic Castration-resistant Metastatic Castration Resistant Prostate Cancer | Phase 3 | 2017-06-13 |
| Completed | ARIEL4: A Study of Rucaparib Versus Chemotherapy BRCA Mutant Ovarian, Fallopian Tube, or Primary Peritoneal Ca Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 3 | 2017-03-01 |
| Completed | A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombina Metastatic Castration Resistant Prostate Cancer | Phase 2 | 2017-02-15 |
| Completed | Absorption, Metabolism, and Excretion Following a Single Oral Dose of [14C]-Rucaparib Solid Tumor | Phase 1 | 2016-11-01 |
| Completed | Panobinostat/Bortezomib/Dexamethasone in Relapsed or Relapsed-and-refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2016-04-27 |
| Completed | Pharmacokinetic Drug-Drug Interaction Study of Rucaparib Neoplasms | Phase 1 | 2016-04-01 |
| Completed | Phase 3 Study of Rucaparib as Switch Maintenance After Platinum in Relapsed High Grade Serous or Endometrioid Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | Phase 3 | 2014-04-07 |
| Completed | A Study of Rucaparib in Patients With Pancreatic Cancer and a Known Deleterious BRCA Mutation Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma | Phase 2 | 2014-04-01 |
| Completed | A Study of Rucaparib in Patients With Platinum-Sensitive, Relapsed, High-Grade Epithelial Ovarian, Fallopian T Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | 2013-10-30 |
| Completed | A Study of Oral Rucaparib in Patients With a Solid Tumor (Phase I) or With gBRCA Mutation Ovarian Cancer (Phas Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer | Phase 1 / Phase 2 | 2011-11-01 |
| Completed | A Study Of Poly (ADP-Ribose) Polymerase Inhibitor PF-01367338 In Combination With Several Chemotherapeutic Reg Advanced Solid Tumors | Phase 1 | 2010-02-01 |